search
Back to results

Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile in Total Knee Arthroplasty Surgery?

Primary Purpose

Osteoarthritis

Status
Completed
Phase
Phase 4
Locations
Korea, Republic of
Study Type
Interventional
Intervention
ferric carboxymaltose 1000 mg
placebo
Sponsored by
Konkuk University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis focused on measuring osteoarthritis, knee arthroplasty, iron

Eligibility Criteria

19 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with osteoarthritis in knee joint undergoing elective uni-limb total knee arthroplasty surgery
  • Patients provided a written informed consent.
  • Patients with s-ferritin < 300 mg/dl (male) or 200 mg/dl (female)
  • Patients with preoperative serum hemoglobin concentration >10 g/dL
  • Patients with PaO2/FiO2 ratio >150

Exclusion Criteria:

  • Patients with history of anaphylaxis, iron overload, active infection.
  • Patients received or receiving intraoperative and preoperative blood salvaged, allogenic blood transfusion, recombinant human erythropoietin, or undergoing acute normovolemic hemodilution.

Sites / Locations

  • Konkuk University Medical Center & Asan Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Experimental group

Control group

Arm Description

ferric carboxymaltose 1000 mg

placebo

Outcomes

Primary Outcome Measures

The changes of Hemoglobin between preoperative and postoperative day 30
intergroup-difference in hemoglobin change
the changes of arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
intergroup-difference in PaO2/FiO2 ratio

Secondary Outcome Measures

arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
intergroup-difference in PaO2/FiO2 ratio
arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
intergroup-difference in PaO2/FiO2 ratio
arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
intergroup-difference in PaO2/FiO2 ratio
serum hemoglobin concentration
Intergroup difference of serum hemoglobin concentration, g/dL
serum hemoglobin concentration
Intergroup difference of serum hemoglobin concentration, g/dL
serum hemoglobin concentration
Intergroup difference of serum hemoglobin concentration, g/dL

Full Information

First Posted
September 3, 2015
Last Updated
September 17, 2019
Sponsor
Konkuk University Medical Center
Collaborators
Asan Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT02544464
Brief Title
Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile in Total Knee Arthroplasty Surgery?
Official Title
Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile and the Recovery of Hemoglobin in Total Knee and Hip Arthroplasty Surgery?
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
August 2016 (Actual)
Primary Completion Date
December 2018 (Actual)
Study Completion Date
January 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Konkuk University Medical Center
Collaborators
Asan Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The objective of the present study is to determine the impact of intraoperative IV-iron supplementation on postoperative oxygenation profile by comparing the postoperative PaO2/FiO2 ratio with or without IV-iron supplementation in old patients undergoing elective uni-limb total knee arthroplasty surgery.
Detailed Description
Participation and recruitment: Patients undergoing elective total knee arthroplasty due to osteoarthritis will be interviewed for participation and recruited after providing written informed consent. Randomization and group allocation: All recruited patients will be given patient identification number (PIN) for the present study of 01-77 according to their order of interview and recruitment. Investigators will prepare 33 yellow and 34 green cards, which will be inserted in 77 thick-paper envelopes. Then, all envelopes will be sealed, mixed and randomly allocated to get numbers of 01 to 77 (Envelop number). After printing the envelope number outside envelope, all sealed envelopes with cards will be conveyed to and kept in pharmacy department. Preparation and Administration of study drug: Pharmacist will open the envelope with the number same to PIN and check the color of the card inside at study on operation day. According to the color of the card, IV-iron or placebo will be prepared for the patient: IV-iron for yellow card; placebo for green cards, respectively. The study drug was employed as "open labelled". IV-iron or placebo will be infused through already established intravenous line within 30 min after anesthesia induction by attending anesthesiologist who is aware of the patient's group-allocation. Patient data and statistical analyses: The information regarding the patient's group allocation will be kept in the pharmacy department till the end of the study and conveyed during the data analyses after completion of the 77th patient participation and discharge. Patient's data PaO2, FiO2, Hb, intra-op and postop-transfusion amount, intraop- and postop-bleeding amount will be determined from the patients' medical record after patient's discharge. All statistical analyses will be performed after the 77th patient's discharge and data acquisition. Surgical procedures: All surgical procedures will be performed using standardized institutional anesthetic and surgical protocols, antibiotic and antithrombotic prophylaxis, transfusion protocols, and post-operative analgesia. All TKA will be performed using a pneumatic tourniquet, which is deflated after wound closure. Closed suction drains, which are removed on the second post-operative day, will be placed in all operations. Transfusion protocol: Following allogenic blood transfusion protocol will be uniformly applied by anesthesiologists and surgeons to all patients in the operating theater, the post-operative anesthesia care unit, and the ward for the entire duration of hospitalization: blood transfusion of packed RBC will not be performed unless patient's Hb level is < 9 g/dL without any signs and/or symptoms of acute anemia such as hypotension, tachycardia, tachypnea, dizziness, and fatigue.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
osteoarthritis, knee arthroplasty, iron

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
76 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental group
Arm Type
Experimental
Arm Description
ferric carboxymaltose 1000 mg
Arm Title
Control group
Arm Type
Placebo Comparator
Arm Description
placebo
Intervention Type
Drug
Intervention Name(s)
ferric carboxymaltose 1000 mg
Other Intervention Name(s)
Ferrinject
Intervention Description
Ferric carboxymaltose is administered after anesthesia induction
Intervention Type
Drug
Intervention Name(s)
placebo
Other Intervention Name(s)
normal saline
Intervention Description
placebo (normal saline) is administered after anesthesia induction
Primary Outcome Measure Information:
Title
The changes of Hemoglobin between preoperative and postoperative day 30
Description
intergroup-difference in hemoglobin change
Time Frame
postoperative 30 days
Title
the changes of arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
Description
intergroup-difference in PaO2/FiO2 ratio
Time Frame
postoperative 5 days
Secondary Outcome Measure Information:
Title
arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
Description
intergroup-difference in PaO2/FiO2 ratio
Time Frame
postoperative 1 day
Title
arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
Description
intergroup-difference in PaO2/FiO2 ratio
Time Frame
postoperative 3 days
Title
arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
Description
intergroup-difference in PaO2/FiO2 ratio
Time Frame
postoperative 5 days
Title
serum hemoglobin concentration
Description
Intergroup difference of serum hemoglobin concentration, g/dL
Time Frame
postoperative 1 day
Title
serum hemoglobin concentration
Description
Intergroup difference of serum hemoglobin concentration, g/dL
Time Frame
postoperative 5 days
Title
serum hemoglobin concentration
Description
Intergroup difference of serum hemoglobin concentration, g/dL
Time Frame
postoperative 30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with osteoarthritis in knee joint undergoing elective uni-limb total knee arthroplasty surgery Patients provided a written informed consent. Patients with s-ferritin < 300 mg/dl (male) or 200 mg/dl (female) Patients with preoperative serum hemoglobin concentration >10 g/dL Patients with PaO2/FiO2 ratio >150 Exclusion Criteria: Patients with history of anaphylaxis, iron overload, active infection. Patients received or receiving intraoperative and preoperative blood salvaged, allogenic blood transfusion, recombinant human erythropoietin, or undergoing acute normovolemic hemodilution.
Facility Information:
Facility Name
Konkuk University Medical Center & Asan Medical Center
City
Seoul
Country
Korea, Republic of

12. IPD Sharing Statement

Learn more about this trial

Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile in Total Knee Arthroplasty Surgery?

We'll reach out to this number within 24 hrs